Gallagher Kathleen P. sold RNA
September 18, 2026 · Form 4 insider transaction
Gallagher Kathleen P. sold 11,632 shares of Atrium Therapeutics, Inc. at $8.95 per share, a transaction worth $104.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
11,632
Price
$8.95
Total value
$104.1K
InsiderGallagher Kathleen P.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateSeptember 18, 2026
Filing dateSeptember 22, 2026
Shares owned after119,729
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.